Home Reimbursed medicines Methotrexat
Methotrexat — maximum prices and reimbursement
The CANAMED catalogue contains 95 medicines with the active substance Methotrexat, from 10 manufacturers. Below you can see each entry with the brand name, the manufacturer, the maximum retail price, the reimbursement percentage and the prescription status — plus live pharmacy prices, where we track them.
95
CANAMED entries
10
Manufacturers
50.90–891.47
Maximum price (RON)
32
With a reimbursement percentage
In short: for the active substance Methotrexat there are 95 authorised medicines in the CANAMED catalogue, with maximum retail prices between 50.90 and 891.47 RON, from 10 manufacturers. For 32 of them the catalogue also records the reimbursement percentage. The maximum price is the legal cap — pharmacies may sell below it, so it is worth comparing the real price before you go. Latest import: 2026-11-03.
Data verified on from public sources (OpenStreetMap, chain websites, ANM/MS) — updated daily.
CANAMED catalogue
All medicines with Methotrexat
Maximum retail price = the legal selling cap. Sorted by price, lowest first.
| Brand name | Manufacturer | Maximum price | Reimbursement | Prescription |
|---|---|---|---|---|
| METOTREXAT SANDOZ 2,5 mg (vezi L04AX03) | LEK PHARMACEUTICALS D.D. - SLOVENIA | 50.90 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~50.90 RON; you ~0.00 RON* |
PR |
| METORTHRIT 10 mg/ml | ROMPHARM COMPANY S.R.L. - ROMANIA | 56.73 RON | 100% · C1 (certain chronic diseases) CNAS pays ~56.73 RON; you ~0.00 RON* |
PR |
| METOTREXAT EBEWE 10 mg/ml | EBEWE PHARMA GES.M.B.H. NFG. KG - AUSTRIA | 57.23 RON | 100% · C1 (certain chronic diseases) CNAS pays ~52.52 RON; you ~4.71 RON* |
PR |
| METOTREXAT EBEWE 10 mg/ml | EBEWE PHARMA GES.M.B.H. NFG. KG - AUSTRIA | 72.47 RON | 100% · C1 (certain chronic diseases) CNAS pays ~61.12 RON; you ~11.35 RON* |
PR |
| METORTHRIT 10 mg/ml | ROMPHARM COMPANY S.R.L. - ROMANIA | 72.63 RON | 100% · C1 (certain chronic diseases) CNAS pays ~52.52 RON; you ~20.11 RON* |
PR |
| METORTHRIT 10 mg/ml | ROMPHARM COMPANY S.R.L. - ROMANIA | 90.42 RON | 100% · C1 (certain chronic diseases) CNAS pays ~76.84 RON; you ~13.58 RON* |
PR |
| NORDIMET 12,5 mg | CENEXI - LABORATOIRES THISSEN S.A. - BELGIA | 93.11 RON | 100% · C1 (certain chronic diseases) CNAS pays ~93.11 RON; you ~0.00 RON* |
PR |
| NORDIMET 15 mg | CENEXI -LABORATOIRES THISSEN S.A. - BELGIA | 99.17 RON | 100% · C1 (certain chronic diseases) CNAS pays ~76.84 RON; you ~22.33 RON* |
PR |
| METOTREXAT EBEWE 10 mg/ml | EBEWE PHARMA GES.M.B.H. NFG. KG - AUSTRIA | 106.18 RON | 100% · C1 (certain chronic diseases) CNAS pays ~76.84 RON; you ~29.34 RON* |
PR |
| NORDIMET 17,5 mg | CENEXI -LABORATOIRES THISSEN S.A. - BELGIA | 112.30 RON | 100% · C1 (certain chronic diseases) CNAS pays ~112.30 RON; you ~0.00 RON* |
PR |
| NORDIMET 20 mg | CENEXI -LABORATOIRES THISSEN S.A. - BELGIA | 121.95 RON | 100% · C1 (certain chronic diseases) CNAS pays ~93.67 RON; you ~28.28 RON* |
PR |
| NORDIMET 22,5 mg | CENEXI -LABORATOIRES THISSEN S.A. - BELGIA | 129.55 RON | 100% · C1 (certain chronic diseases) CNAS pays ~129.55 RON; you ~0.00 RON* |
PR |
| NORDIMET 25 mg | CENEXI -LABORATOIRES THISSEN S.A. - BELGIA | 133.71 RON | 100% · C1 (certain chronic diseases) CNAS pays ~111.14 RON; you ~22.57 RON* |
PR |
| METOTREXAT EBEWE 10 mg/ml | EBEWE PHARMA GES.M.B.H. NFG. KG - AUSTRIA | 138.18 RON | 100% · C1 (certain chronic diseases) CNAS pays ~93.67 RON; you ~44.51 RON* |
PR |
| METORTHRIT 10 mg/ml | ROMPHARM COMPANY S.R.L. - ROMANIA | 141.63 RON | 100% · C1 (certain chronic diseases) CNAS pays ~93.67 RON; you ~47.96 RON* |
PR |
| NAMAXIR 7,5 mg | BIOMEDICA FOSCAMA INDUSTRIA CHIMICO-FARMACEUTICA S.P.A. - ITALIA | 175.08 RON | 100% · C1 (certain chronic diseases) CNAS pays ~175.08 RON; you ~0.00 RON* |
PR |
| NAMAXIR 10 mg | BIOMEDICA FOSCAMA INDUSTRIA CHIMICO-FARMACEUTICA S.P.A. - ITALIA | 203.73 RON | 100% · C1 (certain chronic diseases) CNAS pays ~203.73 RON; you ~0.00 RON* |
PR |
| NAMAXIR 15 mg | BIOMEDICA FOSCAMA INDUSTRIA CHIMICO-FARMACEUTICA S.P.A. - ITALIA | 256.12 RON | 100% · C1 (certain chronic diseases) CNAS pays ~256.12 RON; you ~0.00 RON* |
PR |
| NORDIMET 10 mg | CENEXI -LABORATOIRES THISSEN S.A. - BELGIA | 279.84 RON | 100% · C1 (certain chronic diseases) CNAS pays ~244.48 RON; you ~35.36 RON* |
PR |
| NORDIMET 10 mg | CENEXI - LABORATOIRES THISSEN S.A. - BELGIA | 279.84 RON | 100% · C1 (certain chronic diseases) CNAS pays ~244.48 RON; you ~35.36 RON* |
PR |
| NAMAXIR 20 mg | BIOMEDICA FOSCAMA INDUSTRIA CHIMICO-FARMACEUTICA S.P.A. - ITALIA | 312.25 RON | 100% · C1 (certain chronic diseases) CNAS pays ~312.25 RON; you ~0.00 RON* |
PR |
| NORDIMET 12,5 mg | CENEXI - LABORATOIRES THISSEN S.A. - BELGIA | 328.52 RON | 100% · C1 (certain chronic diseases) CNAS pays ~328.52 RON; you ~0.00 RON* |
PR |
| NORDIMET 12,5 mg | CENEXI - LABORATOIRES THISSEN S.A. - BELGIA | 330.98 RON | 100% · C1 (certain chronic diseases) CNAS pays ~330.98 RON; you ~0.00 RON* |
PR |
| NORDIMET 15 mg | CENEXI - LABORATOIRES THISSEN S.A. - BELGIA | 367.89 RON | 100% · C1 (certain chronic diseases) CNAS pays ~307.34 RON; you ~60.55 RON* |
PR |
| NAMAXIR 25 mg | BIOMEDICA FOSCAMA INDUSTRIA CHIMICO-FARMACEUTICA S.P.A. - ITALIA | 370.45 RON | 100% · C1 (certain chronic diseases) CNAS pays ~370.45 RON; you ~0.00 RON* |
PR |
| NORDIMET 15 mg | CENEXI -LABORATOIRES THISSEN S.A. - BELGIA | 374.72 RON | 100% · C1 (certain chronic diseases) CNAS pays ~307.34 RON; you ~67.38 RON* |
PR |
| NORDIMET 17,5 mg | CENEXI - LABORATOIRES THISSEN S.A. - BELGIA | 410.36 RON | 100% · C1 (certain chronic diseases) CNAS pays ~410.36 RON; you ~0.00 RON* |
PR |
| NORDIMET 20 mg | CENEXI - LABORATOIRES THISSEN S.A. - BELGIA | 440.98 RON | 100% · C1 (certain chronic diseases) CNAS pays ~374.70 RON; you ~66.28 RON* |
PR |
| NORDIMET 20 mg | CENEXI -LABORATOIRES THISSEN S.A. - BELGIA | 447.51 RON | 100% · C1 (certain chronic diseases) CNAS pays ~374.70 RON; you ~72.81 RON* |
PR |
| METHOTREXAT \"EBEWE\" 5000 mg/50 ml | EBEWE PHARMA GES.M.B.H. NFG, KG - AUSTRIA | 454.39 RON | 100% · C2 (national programmes) CNAS pays ~454.39 RON; you ~0.00 RON* |
PR |
| NORDIMET 22,5 mg | CENEXI - LABORATOIRES THISSEN S.A. - BELGIA | 469.21 RON | 100% · C1 (certain chronic diseases) CNAS pays ~469.21 RON; you ~0.00 RON* |
PR |
| JYLAMVO 2 mg/ml | A FINE HOUSE S.A. - GRECIA | 891.47 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~891.47 RON; you ~0.00 RON* |
PR |
| METHOTREXAT EBEWE 20 mg/ml | EBEWE PHARMA GES.M.B.H. NFG. KG - AUSTRIA | — | not reimbursed | PR |
| METHOTREXAT EBEWE 20 mg/ml | EBEWE PHARMA GES.M.B.H. NFG. KG - AUSTRIA | — | not reimbursed | PR |
| METHOTREXAT EBEWE 20 mg/ml | EBEWE PHARMA GES.M.B.H. NFG. KG - AUSTRIA | — | not reimbursed | PR |
| METHOTREXAT EBEWE 20 mg/ml | EBEWE PHARMA GES.M.B.H. NFG. KG - AUSTRIA | — | not reimbursed | PR |
| METHOTREXAT EBEWE 20 mg/ml | EBEWE PHARMA GES.M.B.H. NFG. KG - AUSTRIA | — | not reimbursed | PR |
| METHOTREXAT EBEWE 20 mg/ml | EBEWE PHARMA GES.M.B.H. NFG. KG - AUSTRIA | — | not reimbursed | PR |
| METHOTREXAT EBEWE 20 mg/ml | EBEWE PHARMA GES.M.B.H. NFG. KG - AUSTRIA | — | not reimbursed | PR |
| METHOTREXAT EBEWE 20 mg/ml | EBEWE PHARMA GES.M.B.H. NFG. KG - AUSTRIA | — | not reimbursed | PR |
| METHOTREXAT EBEWE 20 mg/ml | EBEWE PHARMA GES.M.B.H. NFG. KG - AUSTRIA | — | not reimbursed | PR |
| METHOTREXAT EBEWE 20 mg/ml | EBEWE PHARMA GES.M.B.H. NFG. KG - AUSTRIA | — | not reimbursed | PR |
| METHOTREXAT EBEWE 20 mg/ml | EBEWE PHARMA GES.M.B.H. NFG. KG - AUSTRIA | — | not reimbursed | PR |
| METHOTREXAT EBEWE 20 mg/ml | EBEWE PHARMA GES.M.B.H. NFG. KG - AUSTRIA | — | not reimbursed | PR |
| METHOTREXAT EBEWE 20 mg/ml | EBEWE PHARMA GES.M.B.H. NFG. KG - AUSTRIA | — | not reimbursed | PR |
| METHOTREXAT EBEWE 20 mg/ml | EBEWE PHARMA GES.M.B.H. NFG. KG - AUSTRIA | — | not reimbursed | PR |
| METHOTREXAT EBEWE 20 mg/ml | EBEWE PHARMA GES.M.B.H. NFG. KG - AUSTRIA | — | not reimbursed | PR |
| METORTHRIT 10 mg/ml | ROMPHARM COMPANY S.R.L. - ROMANIA | — | not reimbursed | PR |
| METORTHRIT 10 mg/ml | ROMPHARM COMPANY S.R.L. - ROMANIA | — | not reimbursed | PR |
| METORTHRIT 10 mg/ml | ROMPHARM COMPANY S.R.L. - ROMANIA | — | not reimbursed | PR |
| METORTHRIT 10 mg/ml | ROMPHARM COMPANY S.R.L. - ROMANIA | — | not reimbursed | PR |
| METORTHRIT 10 mg/ml | ROMPHARM COMPANY S.R.L. - ROMANIA | — | not reimbursed | PR |
| METORTHRIT 10 mg/ml | ROMPHARM COMPANY S.R.L. - ROMANIA | — | not reimbursed | PR |
| METORTHRIT 10 mg/ml | ROMPHARM COMPANY S.R.L. - ROMANIA | — | not reimbursed | PR |
| METORTHRIT 10 mg/ml | ROMPHARM COMPANY S.R.L. - ROMANIA | — | not reimbursed | PR |
| METOTREXAT EBEWE 10 mg/ml | EBEWE PHARMA GES.M.B.H. NFG. KG - AUSTRIA | — | not reimbursed | PR |
| METOTREXAT EBEWE 10 mg/ml | EBEWE PHARMA GES.M.B.H. NFG. KG - AUSTRIA | — | not reimbursed | PR |
| METOTREXAT EBEWE 10 mg/ml | EBEWE PHARMA GES.M.B.H. NFG. KG - AUSTRIA | — | not reimbursed | PR |
| METOTREXAT EBEWE 10 mg/ml | EBEWE PHARMA GES.M.B.H. NFG. KG - AUSTRIA | — | not reimbursed | PR |
| METOTREXAT EBEWE 10 mg/ml | EBEWE PHARMA GES.M.B.H. NFG. KG - AUSTRIA | — | not reimbursed | PR |
| METOTREXAT EBEWE 10 mg/ml | EBEWE PHARMA GES.M.B.H. NFG. KG - AUSTRIA | — | not reimbursed | PR |
| METOTREXAT EBEWE 10 mg/ml | EBEWE PHARMA GES.M.B.H. NFG. KG - AUSTRIA | — | not reimbursed | PR |
| METOTREXAT EBEWE 10 mg/ml | EBEWE PHARMA GES.M.B.H. NFG. KG - AUSTRIA | — | not reimbursed | PR |
| METOTREXAT SANDOZ 2,5 mg (vezi L04AX03) | LEK PHARMACEUTICALS D.D. - SLOVENIA | — | not reimbursed | PR |
| METOTREXAT SANDOZ 2,5 mg (vezi L04AX03) | LEK PHARMACEUTICALS D.D. - SLOVENIA | — | not reimbursed | PR |
| METOTREXAT SANDOZ 2,5 mg (vezi L04AX03) | LEK PHARMACEUTICALS D.D. - SLOVENIA | — | not reimbursed | PR |
| METOTREXAT SANDOZ 2,5 mg (vezi L04AX03) | LEK PHARMACEUTICALS D.D. - SLOVENIA | — | not reimbursed | PR |
| METOTREXAT VITEMA 2,5 mg | VITEMA S.A. - ROMANIA | — | not reimbursed | PR |
| NAMAXIR 10 mg | BIOMEDICA FOSCAMA INDUSTRIA CHIMICO-FARMACEUTICA S.P.A. - ITALIA | — | not reimbursed | PR |
| NAMAXIR 10 mg | BIOMEDICA FOSCAMA INDUSTRIA CHIMICO-FARMACEUTICA S.P.A. - ITALIA | — | not reimbursed | PR |
| NAMAXIR 15 mg | BIOMEDICA FOSCAMA INDUSTRIA CHIMICO-FARMACEUTICA S.P.A. - ITALIA | — | not reimbursed | PR |
| NAMAXIR 15 mg | BIOMEDICA FOSCAMA INDUSTRIA CHIMICO-FARMACEUTICA S.P.A. - ITALIA | — | not reimbursed | PR |
| NAMAXIR 15 mg | BIOMEDICA FOSCAMA INDUSTRIA CHIMICO-FARMACEUTICA S.P.A. - ITALIA | — | not reimbursed | PR |
| NAMAXIR 20 mg | BIOMEDICA FOSCAMA INDUSTRIA CHIMICO-FARMACEUTICA S.P.A. - ITALIA | — | not reimbursed | PR |
| NAMAXIR 20 mg | BIOMEDICA FOSCAMA INDUSTRIA CHIMICO-FARMACEUTICA S.P.A. - ITALIA | — | not reimbursed | PR |
| NAMAXIR 25 mg | BIOMEDICA FOSCAMA INDUSTRIA CHIMICO-FARMACEUTICA S.P.A. - ITALIA | — | not reimbursed | PR |
| NAMAXIR 25 mg | BIOMEDICA FOSCAMA INDUSTRIA CHIMICO-FARMACEUTICA S.P.A. - ITALIA | — | not reimbursed | PR |
| NAMAXIR 7,5 mg | BIOMEDICA FOSCAMA INDUSTRIA CHIMICO-FARMACEUTICA S.P.A. - ITALIA | — | not reimbursed | PR |
| NAMAXIR 7,5 mg | BIOMEDICA FOSCAMA INDUSTRIA CHIMICO-FARMACEUTICA S.P.A. - ITALIA | — | not reimbursed | PR |
| NORDIMET 10 mg | CENEXI -LABORATOIRES THISSEN S.A. - BELGIA | — | not reimbursed | PR |
| NORDIMET 10 mg | CENEXI - LABORATOIRES THISSEN S.A. - BELGIA | — | not reimbursed | PR |
| NORDIMET 12,5 mg | CENEXI - LABORATOIRES THISSEN S.A. - BELGIA | — | not reimbursed | PR |
| NORDIMET 15 mg | CENEXI - LABORATOIRES THISSEN S.A. - BELGIA | — | not reimbursed | PR |
| NORDIMET 17,5 mg | CENEXI -LABORATOIRES THISSEN S.A. - BELGIA | — | not reimbursed | PR |
| NORDIMET 17,5 mg | CENEXI - LABORATOIRES THISSEN S.A. - BELGIA | — | not reimbursed | PR |
| NORDIMET 20 mg | CENEXI - LABORATOIRES THISSEN S.A. - BELGIA | — | not reimbursed | PR |
| NORDIMET 22,5 mg | CENEXI -LABORATOIRES THISSEN S.A. - BELGIA | — | not reimbursed | PR |
| NORDIMET 22,5 mg | CENEXI - LABORATOIRES THISSEN S.A. - BELGIA | — | not reimbursed | PR |
| NORDIMET 25 mg | CENEXI -LABORATOIRES THISSEN S.A. - BELGIA | — | not reimbursed | PR |
| NORDIMET 25 mg | CENEXI - LABORATOIRES THISSEN S.A. - BELGIA | — | not reimbursed | PR |
| NORDIMET 25 mg | CENEXI - LABORATOIRES THISSEN S.A. - BELGIA | — | not reimbursed | PR |
| NORDIMET 7,5 mg | CENEXI -LABORATOIRES THISSEN S.A. - BELGIA | — | not reimbursed | PR |
| NORDIMET 7,5 mg | CENEXI -LABORATOIRES THISSEN S.A. - BELGIA | — | not reimbursed | PR |
| NORDIMET 7,5 mg | CENEXI - LABORATOIRES THISSEN S.A. - BELGIA | — | not reimbursed | PR |
| NORDIMET 7,5 mg | CENEXI - LABORATOIRES THISSEN S.A. - BELGIA | — | not reimbursed | PR |
Reimbursement and amounts come from the CNAS nomenclature (SIUI) valid in the current month, for each pack. *What you pay is indicative: the maximum price minus what CNAS pays on the main sublist, for an insured adult. The pharmacy may sell below the maximum price; low-income pensioners, children, pupils and pregnant women may pay less. C1 applies only to the diseases on the list, and C2 within the national programmes.
Prescription status key:
- PR — With a medical prescription (PR)
Live pharmacy prices
Products with Methotrexat in our comparator
Shelf prices collected from the large chains — see on each product page where it is cheapest.
- JYLAMVO 2 mg/ml
- METHOTREXAT EBEWE 20 mg/ml
- METHOTREXAT EBEWE 20 mg/ml
- METHOTREXAT EBEWE 20 mg/ml
- METHOTREXAT EBEWE 20 mg/ml
- METHOTREXAT EBEWE 20 mg/ml
- METHOTREXAT EBEWE 20 mg/ml
- METHOTREXAT EBEWE 20 mg/ml
- METHOTREXAT EBEWE 20 mg/ml
- METHOTREXAT EBEWE 20 mg/ml
- METHOTREXAT EBEWE 20 mg/ml
- METHOTREXAT EBEWE 20 mg/ml
Good to know
How to read the maximum price
The CANAMED maximum retail price is the legal cap approved by the Ministry of Health — the pharmacy may sell for less, never for more. If the medicine is reimbursed, the sublist percentage (A 90%, B 50%, C1/C2 100%, D 20%) applies to the reference price of the therapeutic group, usually calculated from the cheapest product with the same INN — which is why your contribution can differ from one brand to another, even for the same active substance. The electronic prescription automatically shows the exact amount to pay; for non-prescription shelf prices, use the HartaFarmacii comparator.
CANAMED catalogue
Other active substances in the catalogue
- Metformin
- Memantin
- Metoprolol
- Montelukast
- Midazolam
- Moxifloxacin
- Metamizol natri
- Meropenem
- Mirabegron
- Mesalazin
See also the full list of reimbursed medicines, with an alphabetical index of all active substances.
Frequently asked questions
FAQ · Methotrexat
-
Is Methotrexat reimbursed?
Yes. For 32 of the catalogue entries with Methotrexat we have the reimbursement percentage on record. The percentage depends on the CNAS sublist each product is placed on (A 90%, B 50%, C1/C2 100%, D 20%) and applies to the reference price of the therapeutic group, not to the shelf price. Ask the doctor or pharmacist for the exact placement. -
What is the CANAMED maximum price for Methotrexat?
The maximum retail prices (the CANAMED legal cap) for medicines with Methotrexat are between 50.90 and 891.47 RON. No pharmacy may sell above the maximum price, but it may sell below it — compare real prices with the HartaFarmacii comparator. -
What percentage of Methotrexat is reimbursed?
The percentage depends on the CNAS sublist: A 90% (common chronic diseases), B 50% (partial reimbursement), C1 and C2 100% (serious chronic diseases and national programmes), D 20%. The percentage applies to the reference price set by CNAS, not to the shelf price, so you may pay a difference even for a “100% reimbursed” medicine. You can see the exact placement on the electronic prescription. -
How many medicines with Methotrexat are in the CANAMED catalogue?
The CANAMED catalogue holds 95 authorised medicines with the active substance Methotrexat — different brand names, strengths and pharmaceutical forms. You will find them all, with maximum price and prescription status, in the table on this page. Latest CANAMED import into the HartaFarmacii database: 2026-11-03.
Before you go